Security Snapshot

Medtronic - COM (MDT) Institutional Ownership

CUSIP: 585055106

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

8

Shares (Excl. Options)

680,197

Price

$96.06

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COM
Symbol
MDT on NYSE
Price per share
$86.65
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
680,197
Total reported value
$65,339,480
% of total 13F portfolios
0%
Share change
+18,951
Value change
+$1,821,313
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • MDT - Medtronic - COM is tracked under CUSIP 585055106.
  • 8 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 8 to 5 between Q4 2025 and Q1 2026.
  • Reported value moved from $65,339,480 to $57,536,027.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 8 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 585055106?
CUSIP 585055106 identifies MDT - Medtronic - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 8 institutional investors reported holding 680,197 shares of Medtronic - COM (MDT).

Institutional Holders of Medtronic - COM (MDT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 664,006 $57,536,027 -$567,811 $86.65 5
2025 Q4 680,197 $65,339,480 +$1,821,313 $96.06 8
2025 Q3 661,246 $62,977,168 +$309,116 $95.24 7
2025 Q2 658,094 $57,366,110 -$362,015 $87.17 7
2025 Q1 662,312 $59,509,782 -$6,475,888 $89.86 8
2024 Q4 748,427 $58,984,246 -$5,528,595 $79.88 11
2024 Q3 773,690 $69,649,811 +$159,851 $90.03 15
2024 Q2 768,270 $60,471,972 -$792,214 $78.71 14
2024 Q1 778,276 $67,669,557 -$15,186,364 $87.15 14
2023 Q4 857,738 $70,689,506 -$2,054,015 $82.38 14
2023 Q3 976,667 $76,585,545 +$552,688 $78.36 14
2023 Q2 967,064 $85,175,027 +$63,252,911 $88.10 16
2023 Q1 250,685 $20,186,390 -$5,224,962 $80.62 16
2022 Q4 318,551 $24,762,969 -$121,929,903 $77.72 17
2022 Q3 1,822,263 $147,167,875 -$236,701,090 $80.75 19
2022 Q2 4,753,532 $426,631,375 -$16,278,610 $89.76 20
2022 Q1 4,897,853 $543,434,175 -$25,579,145 $110.95 22
2021 Q4 5,137,747 $531,533,425 -$45,722,527 $103.45 20
2021 Q3 5,508,013 $690,446,000 -$13,747,806 $125.35 24
2021 Q2 5,618,012 $697,382,845 -$173,654,777 $124.13 30
2021 Q1 5,908,626 $698,001,138 -$30,785,494 $118.13 30
2020 Q4 7,349,398 $860,296,000 +$82,077,221 $117.14 32
2020 Q3 6,646,878 $690,747,000 +$56,754,453 $103.92 30
2020 Q2 6,101,631 $559,490,456 +$168,663,076 $91.70 30
2020 Q1 4,261,574 $384,345,048 +$155,702,202 $90.18 31
2019 Q4 2,496,310 $283,341,000 -$16,686,294 $113.45 35
2019 Q3 2,668,181 $289,808,000 -$31,847,405 $108.62 38
2019 Q2 2,997,940 $292,232,000 +$89,507,327 $97.39 36
2019 Q1 2,080,454 $189,489,000 +$30,642,691 $91.08 38
2018 Q4 1,760,490 $157,478,977 -$23,160,220 $90.96 39
2018 Q3 2,074,873 $204,110,652 -$4,243,315 $98.37 40
2018 Q2 2,120,849 $181,565,056 +$22,571,053 $85.61 38
2018 Q1 1,982,914 $159,119,365 -$11,266,131 $80.22 43
2017 Q4 2,122,162 $168,467,154 -$17,493,964 $80.75 49
2017 Q3 2,359,976 $183,534,465 +$20,033,379 $77.77 49
2017 Q2 2,089,079 $185,399,819 -$6,146,732 $88.75 53
2017 Q1 2,189,634 $176,198,632 -$122,703 $80.56 50
2016 Q4 2,175,795 $154,855,623 +$3,056,150 $71.23 51
2016 Q3 2,246,002 $193,832,768 -$33,174,362 $86.40 54
2016 Q2 2,629,006 $227,617,120 -$28,344,495 $86.77 64
2016 Q1 3,028,985 $227,007,863 -$198,627,343 $75.00 67
2015 Q4 5,563,498 $428,480,536 +$24,684,067 $76.92 77
2015 Q3 5,158,545 $345,606,372 -$118,119,185 $66.94 82
2015 Q2 6,848,534 $507,527,808 -$151,174,343 $74.10 95
2015 Q1 8,559,087 $667,028,580 -$60,348,346,139 $77.99 159
2014 Q4 845,183,714 $61,057,409,516 -$459,459,563 $72.20 1,047
2014 Q3 852,413,799 $52,807,439,375 +$1,716,412,305 $61.95 1,120
2014 Q2 824,662,242 $52,568,205,939 +$3,243,865,519 $63.76 1,097
2014 Q1 773,630,436 $47,584,640,411 +$683,301,110 $61.54 1,064
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .